Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Industry Insights 2025 – Market Forecast for Executives and Planners
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
#How Has The Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Size Shifted, And What Is the Outlook Through 2034?
The market for devices related to chronic obstructive pulmonary disease (COPD) and asthma has experienced significant growth in the recent past. It is projected to increase from $44.95 billion in 2024 to $47.83 billion in 2025, reporting a compound annual growth rate (CAGR) of 6.4%. Factors such as the growth of the aging population, a rise in allergy cases, heightened government initiatives, an increase in clinical research and trials, and growing urbanization can be attributed to the growth experienced during the historic period.
How Much Will the Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Be Worth in 2029?
The market for devices treating chronic obstructive pulmonary disease (COPD) and asthma is poised for significant expansion in the coming years. By 2029, it is projected to reach $60.53 billion, translating to a compound annual growth rate (CAGR) of 6.1%. This growth during the forecasted period can be linked to factors such as an increase in respiratory disease cases, higher cigarette consumption, escalating pollution levels leading to breathing issues, increased incidence of respiratory illnesses, expanding health care costs, and enhanced transportability of drug administration devices. Key trends during this period will comprise technological progression, inclusion of smart technology, personalization of medicine, the use of biologics, and wearable respiratory monitoring devices.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18298&type=smp
Which is the Largest Company in the Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market?
Major companies operating in the chronic obstructive pulmonary disease (COPD) and asthma devices market are AstraZeneca Plc, Novartis AG, GlaxoSmithKline Plc, 3M Health Care, Boehringer Ingelheim, Royal Philips NV, Teva Pharmaceuticals Industries Ltd., Baxter International Inc., Omron Corporation, Smiths Medical Inc., Recipharm AB, Cipla Ltd., Teleflex Incorporated, Chiesi Farmaceutici SpA, Lincre Holdings Inc., Sunovion Pharmaceuticals Inc., Verona Pharma plc, Drive DeVilbiss Healthcare, Pari Respiratory Equipment Inc., Allied Healthcare Products Inc., Clement Clarke International Ltd., Cohero Health Inc., Pneuma Respiratory Inc., Mundipharma International Ltd.
What Are the Main Market Drivers in the Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Industry?
The rising incidence of respiratory illnesses is anticipated to fuel the expansion of the market for chronic obstructive pulmonary disease (COPD) and asthma devices. These respiratory conditions include ailments that affect the lungs and overall respiratory system such as asthma, COPD, pneumonia, and lung cancer that hinder breathing and general respiratory function. The factors contributing to the increased incidence of these diseases include escalating levels of air pollution, changing climatic patterns that affect allergens and pathogens, and lifestyle choices such as smoking that harm respiratory health. Devices for COPD and asthma are key in the holistic management and treatment of these diseases by aiding patients in achieving optimal respiratory health and improving their overall wellness. For instance, in March 2023, the World Health Organization (WHO), the Switzerland-based UN branch responsible for worldwide public health, identified COPD as the third leading cause of death globally, accounting for around 3.23 million deaths. Also, approximately 90% of these fatalities occurred among people below 70 years in low-and middle-income nations. Hence, the surging incidence of these respiratory diseases is spurring the growth of the COPD and Asthma devices markets.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=18298&type=smp
How Is the Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Segments Structured?
The chronic obstructive pulmonary disease (COPD) and asthma devices market covered in this report is segmented –
1) By Type: Metered Dose Inhalers, Drug Powder Inhalers, Soft Mist Inhalers, Jet Nebulizers, Ultrasonic Nebulizers, Other Types
2) By Indication: Asthma, Chronic Obstructive Pulmonary Disease
3) By Application: Hospitals, Clinics, Home Care Settings, Research Institutions, Other Applications
4) By End User: Pediatric, Adult, Geriatric
Subsegments:
1) By Metered Dose Inhalers: Conventional MDI, Breath-Actuated MDI
2) By Drug Powder Inhalers: Dry Powder Inhalers (DPI), Multi-Dose DPI
3) By Soft Mist Inhalers: Respimat Soft Mist Inhalers, Other Soft Mist Devices
4) By Jet Nebulizers: Pneumatic Nebulizers, Venturi-Type Nebulizers
5) By Ultrasonic Nebulizers: Tabletop Ultrasonic Nebulizers, Portable Ultrasonic Nebulizers
6) By Other Types: Nebulizer Accessories, Spacer Devices
What Strategic Trends Are Transforming the Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market?
Leading businesses in the chronic obstructive pulmonary disease (COPD) and asthma devices sector are concentrating on the creation of game-changing technologies like inhalation devices that encompass digital health capabilities for individualized treatment management and distant monitoring. These inhalation devices are pieces of medical equipment utilized to deliver drugs directly into the lungs via inhalation process. For example, in May 2022, Alkem Laboratories, a pharmaceutical firm based in India, launched the Innohaler, a dry powder inhaler (DPI) mechanism, designed to aid individuals suffering from asthma and COPD. The Innohaler features top-notch breath-triggered technology to precisely dispense medication with each inhalation, enhancing dosage exactness while minimizing waste. It is built with a design that facilitates an easy grip, and it comes with a straightforward interface to ease its operation for individuals across all age groups. The device is built lightweight and compact, making it easy to carry around, thus promoting convenience for usage outside of a home or hospital environment, and increasing the likelihood that patients will adhere to their prescribed treatment regime.
Access The Full Report Here:
Which Global Regions Offer the Highest Growth in the Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market?
North America was the largest region in the chronic obstructive pulmonary disease (COPD) and asthma devices market in 2023. The regions covered in the chronic obstructive pulmonary disease (COPD) and asthma devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18298
This Report Delivers Insight On:
1. How big is the chronic obstructive pulmonary disease (copd) and asthma devices market, and how is it changing globally?
2. Who are the major companies in the chronic obstructive pulmonary disease (copd) and asthma devices market, and how are they performing?
3. What are the key opportunities and risks in the chronic obstructive pulmonary disease (copd) and asthma devices market right now?
4. Which products or customer segments are growing the most in the chronic obstructive pulmonary disease (copd) and asthma devices market?
5. What factors are helping or slowing down the growth of the chronic obstructive pulmonary disease (copd) and asthma devices market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model